.alpha.-Adrenergic agents. 2. Synthesis and .alpha.1-agonist activity of 2-aminotetralins

Journal of Medicinal Chemistry
1982.0

Abstract

Substituted 2-aminotetralins are potent, selective, direct-acting agonists at postjunctional alpha 1 receptors. Within this series, substituent alterations on the ring, as well as on the nitrogen, change the potency of compounds by over three orders of magnitude (EC50 = 12 to greater than 10 000 nM). It has been demonstrated experimentally that substitution at both the 5 and 8 positions of the aromatic ring produces optimum agonist potency. Removal of either substituent results in a loss of potency and efficacy relative to norepinephrine. Substitution at positions 6 and/or 7 is generally detrimental to activity. Methyl, ethyl, or dimethyl substitution on nitrogen is compatible with high agonist potency, while substitution with larger groups is not. The most potent agonist in this series is 5-(thiomethyl)-8-methoxy-2-aminotetralin, which has an EC50 of 12 nM.

Knowledge Graph

Similar Paper

.alpha.-Adrenergic agents. 2. Synthesis and .alpha.1-agonist activity of 2-aminotetralins
Journal of Medicinal Chemistry 1982.0
.alpha.-Adrenergic agents. 1. Direct-acting .alpha.1 agonists related to methoxamine
Journal of Medicinal Chemistry 1981.0
.alpha.2-Adrenergic agonists/antagonists: the synthesis and structure-activity relationships of a series of indolin-2-yl and tetrahydroquinolin-2-yl imidazolines
Journal of Medicinal Chemistry 1987.0
Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins
Journal of Medicinal Chemistry 1986.0
Indoline analogs of idazoxan: potent .alpha.2-antagonists and .alpha.1-agonists
Journal of Medicinal Chemistry 1988.0
2-Amido-8-methoxytetralins: A series of nonindolic melatonin-like agents
Journal of Medicinal Chemistry 1993.0
Conformationally defined adrenergic agents. 2. Catechol imidazoline derivatives: biological effects at .alpha.1 and .alpha.2 adrenergic receptors
Journal of Medicinal Chemistry 1986.0
Structure−Activity Studies for a Novel Series ofN-(Arylethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-N-methylamines Possessing Dual 5-HT Uptake Inhibiting and α<sub>2</sub>-Antagonistic Activities
Journal of Medicinal Chemistry 1997.0
Derivatives of (R)-2-amino-5-methoxytetralin: Antagonists and inverse agonists at the dopamine D2a receptor
Bioorganic &amp; Medicinal Chemistry Letters 1999.0
Adrenergic agents. 8. Synthesis and .beta.-adrenergic agonist activity of some 3-tert-butylamino-2-(substituted phenyl)-1-propanols
Journal of Medicinal Chemistry 1977.0